XTL Biopharmaceuticals Ltd (XTLB) — Long-term Investment Intensity
XTL Biopharmaceuticals Ltd (XTLB) has a Long-term Investment Intensity of 0.2% as of December 2024. Long-term investments of ILA14.00K represent 0.2% of total assets of ILA8.55 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check XTL Biopharmaceuticals Ltd (XTLB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
XTL Biopharmaceuticals Ltd Long-term Investment Intensity (2024–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 0.2%, reflecting long-term investments of ILA14.00K against total assets of ILA8.55 Million ILA. Explore XTL Biopharmaceuticals Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for XTL Biopharmaceuticals Ltd (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for XTL Biopharmaceuticals Ltd from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of XTL Biopharmaceuticals Ltd.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.2% | ILA14.00K | ILA8.55 Million | — |